Bliss GVS Pharma Nine Monthly Results

FINANCIALS

Select Period:

Particulars ( Rupees In Crores.)	Dec-2022	Dec-2021	Dec-2020	Dec-2019	Dec-2018
Gross Sales	566.81	580.39	445.15	569.51	654.20
Excise Duty	--	--	--	--	--
Net Sales	566.81	580.39	445.15	569.51	654.20
Other Operating Income	--	--	--	--	--
Other Income	14.81	19.30	13.90	20.52	34.84
Total Income	581.62	599.69	459.05	590.03	689.04
Total Expenditure	455.73	555.81	355.39	462.13	528.50
PBIDT	125.89	43.88	103.66	127.90	160.54
Interest	5.28	3.11	3.15	3.02	3.49
PBDT	120.61	40.77	100.51	124.88	157.05
Depreciation	13.79	13.06	12.96	9.25	6.74
Minority Interest Before NP	--	--	--	--	--
Tax	35.50	33.75	21.01	28.34	42.60
Deferred Tax	(1.95)	(5.70)	0.72	(2.39)	(0.16)
Reported Profit After Tax	73.27	(0.34)	65.82	89.68	107.88
Minority Interest After NP	5.75	4.25	3.57	1.16	2.26
Net Profit after Minority Interest	67.52	(4.59)	62.25	88.52	105.61
Extra-ordinary Items	--	16.05	--	--	--
Adjusted Profit After Extra-ordinary item	67.52	(20.64)	62.25	88.52	105.61
EPS (Unit Curr.)	6.49	(0.44)	6.03	8.58	10.24
Book Value (Unit Curr.)	--	--	--	--	--
Dividend (%)	--	--	--	--	--
Equity	10.37	10.37	10.31	10.31	10.31
Public Shareholding (Number)	--	--	--	--	--
Public Shareholding (%)	--	--	--	--	--
Pledged/Encumbered - No. of Shares	--	--	--	--	--
Pledged/Encumbered - % in Total Promoters Holding	--	--	--	--	--
Pledged/Encumbered - % in Total Equity	--	--	--	--	--
Non Encumbered - No. of Shares	--	--	--	--	--
Non Encumbered - % in Total Promoters Holding	--	--	--	--	--
Non Encumbered - % in Total Equity	--	--	--	--	--
PBIDTM(%)	22.21	7.56	23.29	22.46	24.54
PBDTM(%)	21.28	7.03	22.58	21.93	24.01
PATM(%)	12.93	(0.06)	14.79	15.75	16.49

QuickLinks for Bliss GVS Pharma Ltd.